Skip to main content
ScholarsBetaWeill Cornell Medicine

Overview

Dr Bergman's main research interest is in the treatment of coronary artery disease with stents and other devices that are used in the setting of cardiac catheterization. He is also directly involved in investigating the efficacy and safety of devices used to treat structural heart abnormalities such as atrial septal defects, patent foramen ovale and valvular heart disease including aortic stenosis and mitral regurgitation.

Publications

95 publications

Funding

2 grants
Completed grants (2)
  • Co-I
    Outcomes of Advances in Therapy in Aortic Stenosis
    Michael Wolk Heart Foundation, Inc. · 2017–2020
    MWHFI 17081089-02
  • KP
    Rates of Coronary Artery Revascularization and Outcomes After Percutaneous Coronary Interventions and Coronary Artery Bypass
    New York Cardiac Center, Inc. · 2015–2017
    NYCCI 15071021-01

Clinical research

7 studies
Completed & closed trials (7)
  • PI
    Monitoring of cardiac dynamics by radio sensors in patients with catheter sensors to the heart chambers
    Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2026)
  • PI
    Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
    NA · CathWorks, Inc. · IRB STUDY CLOSURE (as of 2026)
    Percutaneous Coronary Intervention
    NCT05893498
  • PI
    BIOTRONIK - A Prospective Multicenter Study to Confirm the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - VII
    BIOTRONIK GmbH & Co. · IRB STUDY CLOSURE (as of 2026)
    Coronary Artery Disease; Atherosclerosis, Coronary; Myocardial Ischemia; Ischemic Heart Disease; Acute Coronary Syndrome; Angina Pectoris
    NCT04175626
  • PI
    Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
    NA · Abbott Cardiovascular Systems, Inc. · CLOSED TO ACCRUAL (as of 2026)
    Atrial Fibrillation; Stroke; Bleeding
    NCT04226547
  • PI
    PARADIGM PARAvalvular Leak Closure With the Amplatzer Valvular Plug occluDer for Interventional Transcatheter Closure for PVL With Surgical bioloGical and Mechanical Heart Valve
    NA · Abbott Cardiovascular Systems, Inc. · CLOSED TO ACCRUAL (as of 2025)
    Paravalvular Aortic Regurgitation
    NCT04489823
  • PI
    REPRISE IV: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of LOTUS Edge Valve System in IntermediatE Surgical Risk Subjects
    NA · Boston Scientific Corporation · CLOSED TO ACCRUAL (as of 2024)
    Aortic Valve Stenosis
    NCT03618095
  • PI
    SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
    NA · Medtronic, Inc. · CLOSED TO ACCRUAL (as of 2022)
    Symptomatic Aortic Stenosis; Aortic Valve Stenosis; Aortic Valve Replacement
    NCT04722250